Mason Capital Management LLC Bluebird Bio, Inc. Transaction History

Mason Capital Management LLC

  • $69.3 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$11.24 - $21.0 $241,502 - $451,206
-21,486 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$18.04 - $22.09 $117,007 - $143,275
6,486 Added 43.24%
21,486 $687,000
Q1 2021

May 17, 2021
BUY
$16.59 - $33.89 $248,850 - $508,350
15,000 New
15,000 $452,000

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $27M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Mason Capital Management LLC Portfolio

Follow Mason Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email